Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · July 16, 2023

Cholinesterase Inhibitors for the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease and Parkinson's Disease

JAMA Neurology


Additional Info

JAMA Neurology
Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis
JAMA Neurol 2023 Jun 26;[EPub Ahead of Print], E d'Angremont, MJH Begemann, T van Laar, IEC Sommer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading